Education
1979 Bachelor's degree in Biological Science - Università di Ferrara
1987 PhD in Biochemistry - Università di Ferrara
2007 Specialization in Microbiology and Virology, Università di Padova
Brief chronology of employments
1980-1982 Research fellow - Università di Ferrara
1983-1985 Visiting Scientist - The Wistar Institute - Philadelphia USA
1983-1987 PhD student (the Wistar Institute 2 years and University of Ferrara 2 years)
1988-1991 Research Fellow - Dana Farber Cancer Institute, Harvard Medical School - Boston USA
1990-2004 Assistant Professor (MED/07) - Università di Ferrara
Dec 2004-2018 Associate Professor (MED/07) - Università di Padova
Dec 2004-2015 Biologist Manager (University-Hospital agreement) Microbiology and Virology Laboratory – Hospital – Padova
2018-2021 Associate Professor (MED/07) - Università di Ferrara
2021-date Full professor (MEDS-03/A, ex MED/07)- Università di Ferrara
Honors and other recognitions
1979 Summa cum Laude
1987 Summa cum Laude
1983 AIRC Fellowship
1988 AIRC fellowship
1989-1991 Fellowship of the Cancer Research Institute (USA)
1990 Scholarship of the National Leucemia Association (USA)
1998 Biotech Award-Dompè (Italy)
Teaching activity
She has been teaching Microbiology and Virology since 1992 at the School of Medicine, Biology and Pharmacy at the University of Ferrara and the University of Padova.
Research activities
Studies on oncogenic properties of DNA viruses (BK polyomavirus) and RNA viruses (HTLVI). Since 1992 the main research areas have been/are i) pharmacological and therapeutic approaches to inhibit HIV infection; ii) HIV-1 Tat gene activity in cellular and tat-trangenic mice models; iii) HHV-8 and its role in the pathogenesis of Kaposi’s sarcoma and human lymphomas; iv) development of new vaccines against HIV/AIDS; v) immunogenicity and immunemodulation of novel delivery systems for vaccines and gene therapy; vi) development of new vaccines against Herpes simplex virus infection; vii) cellular immune responses after HPV vaccination; viii) immune responses in HCV chronic infection under treatment or not with new direct antiviral agents. She is co-author in more than one hundred publications in international scientific journals and of 5 international patents.
Reviewer activities
International Journals: Vaccine, Journal of Controlled Release, Expert Opinion in Drug Delivery, Gene Therapy, Journal of Medical Virology, Virology Journal, Journal of Infectious Diseases, Future Medicine Journals (Therapeutic Delivery, Nanomedicine), Nature group (Scientific Reports), Frontiers Immunology.
Research Projects: National AIDS Program, National Czech Republic.
1979 Bachelor's degree in Biological Science - Università di Ferrara
1987 PhD in Biochemistry - Università di Ferrara
2007 Specialization in Microbiology and Virology, Università di Padova
Brief chronology of employments
1980-1982 Research fellow - Università di Ferrara
1983-1985 Visiting Scientist - The Wistar Institute - Philadelphia USA
1983-1987 PhD student (the Wistar Institute 2 years and University of Ferrara 2 years)
1988-1991 Research Fellow - Dana Farber Cancer Institute, Harvard Medical School - Boston USA
1990-2004 Assistant Professor (MED/07) - Università di Ferrara
Dec 2004-2018 Associate Professor (MED/07) - Università di Padova
Dec 2004-2015 Biologist Manager (University-Hospital agreement) Microbiology and Virology Laboratory – Hospital – Padova
2018-2021 Associate Professor (MED/07) - Università di Ferrara
2021-date Full professor (MEDS-03/A, ex MED/07)- Università di Ferrara
Honors and other recognitions
1979 Summa cum Laude
1987 Summa cum Laude
1983 AIRC Fellowship
1988 AIRC fellowship
1989-1991 Fellowship of the Cancer Research Institute (USA)
1990 Scholarship of the National Leucemia Association (USA)
1998 Biotech Award-Dompè (Italy)
Teaching activity
She has been teaching Microbiology and Virology since 1992 at the School of Medicine, Biology and Pharmacy at the University of Ferrara and the University of Padova.
Research activities
Studies on oncogenic properties of DNA viruses (BK polyomavirus) and RNA viruses (HTLVI). Since 1992 the main research areas have been/are i) pharmacological and therapeutic approaches to inhibit HIV infection; ii) HIV-1 Tat gene activity in cellular and tat-trangenic mice models; iii) HHV-8 and its role in the pathogenesis of Kaposi’s sarcoma and human lymphomas; iv) development of new vaccines against HIV/AIDS; v) immunogenicity and immunemodulation of novel delivery systems for vaccines and gene therapy; vi) development of new vaccines against Herpes simplex virus infection; vii) cellular immune responses after HPV vaccination; viii) immune responses in HCV chronic infection under treatment or not with new direct antiviral agents. She is co-author in more than one hundred publications in international scientific journals and of 5 international patents.
Reviewer activities
International Journals: Vaccine, Journal of Controlled Release, Expert Opinion in Drug Delivery, Gene Therapy, Journal of Medical Virology, Virology Journal, Journal of Infectious Diseases, Future Medicine Journals (Therapeutic Delivery, Nanomedicine), Nature group (Scientific Reports), Frontiers Immunology.
Research Projects: National AIDS Program, National Czech Republic.
